Publication

The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes

Downloadable Content

Persistent URL
Last modified
  • 06/25/2025
Type of Material
Authors
    Alessio Di Fonzo, Dino Ferrari CenterAlberto Albanese, IRCCS Humanitas Research HospitalHyder Jinnah, Emory University
Language
  • English
Date
  • 2022-08-01
Publisher
  • LIPPINCOTT WILLIAMS & WILKINS
Publication Version
Copyright Statement
  • © 2022, Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 35
Issue
  • 4
Start Page
  • 502
End Page
  • 509
Grant/Funding Information
  • HAJ is supported by grants to The Dystonia Coalition (NS065701, TR001456, NS116025) which is part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported by the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), and the National Institute of Neurological Diseases and Stroke (NINDS). He is also supported by NIH R01 grants (NS109242, NS119758, NS119831).
Abstract
  • Purpose of reviewWe describe here how such mechanisms shared by different genetic forms can give rise to motor performance dysfunctions with a clinical aspect of dystonia.Recent findingsThe continuing discoveries of genetic causes for dystonia syndromes are transforming our view of these disorders. They share unexpectedly common underlying mechanisms, including dysregulation in neurotransmitter signaling, gene transcription, and quality control machinery. The field has further expanded to include forms recently associated with endolysosomal dysfunction.SummaryThe discovery of biological pathways shared between different monogenic dystonias is an important conceptual advance in the understanding of the underlying mechanisms, with a significant impact on the pathophysiological understanding of clinical phenomenology. The functional relationship between dystonia genes could revolutionize current dystonia classification systems, classifying patients with different monogenic forms based on common pathways. The most promising effect of these advances is on future mechanism-based therapeutic approaches.
Author Notes
  • Hyder H. Jinnah, hjinnah@emory.edu, Departments of Neurology, Human Genetics, and Pediatrics, Emory University School of Medicine, Atlanta GA, 30322, USA
Keywords
Research Categories
  • Biology, Genetics
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items